Filipe C. Mariz

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Assessment of Mycobacterium tuberculosis dodecin scaffold as a multimerization platform on the immunogenicity of HPV L2 antigens.

Assessment of Mycobacterium tuberculosis dodecin scaffold as a multimerization platform on the immunogenicity of HPV L2 antigens.

Journal: Scientific reports

Published: May 28, 2025

Editorial: Papillomaviruses, immunity, and tumour development.

Editorial: Papillomaviruses, immunity, and tumour development.

Journal: Frontiers in cellular and infection microbiology

Published: March 25, 2025

Scientific approaches to defining HPV vaccine-induced protective immunity.

Scientific approaches to defining HPV vaccine-induced protective immunity.

Journal: International journal of cancer

Published: September 16, 2024

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.

Journal: NPJ vaccines

Published: January 23, 2024

A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.

A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.

Journal: NPJ vaccines

Published: December 21, 2023

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2.

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2.

Journal: Frontiers in immunology

Published: August 03, 2023

Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity.

Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity.

Journal: NPJ vaccines

Published: July 25, 2023

Scientific approaches toward improving cervical cancer elimination strategies.

Scientific approaches toward improving cervical cancer elimination strategies.

Journal: International journal of cancer

Published: June 20, 2023

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses - A meeting report.

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses - A meeting report.

Journal: Preventive medicine reports

Published: April 21, 2023

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Journal: Frontiers in immunology

Published: August 03, 2022

Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.

Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.

Journal: Frontiers in immunology

Published: May 31, 2022

A broadly protective vaccine against cutaneous human papillomaviruses.

A broadly protective vaccine against cutaneous human papillomaviruses.

Journal: NPJ vaccines

Published: March 31, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026